Discover 1,443 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,443
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
for
Relapsed/Refractory Multiple Myeloma (RRMM)
Location: Tacoma WA, Reno NV, Los Angeles CA, Lubbock TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07609940
Phase 4, Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: Tacoma WA, Salt Lake City UT, Clovis CA, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05552222
Phase 3, Recruiting
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Location: Puyallup WA, Billings MT, Pasadena CA, Beverly Hills CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06679101
Phase 3, Recruiting
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
for
Non Small Cell Lung Carcinoma, c-MET
Location: Tacoma WA, Olympia WA, Salt Lake City UT, Oxnard CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06772623
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Location: Tacoma WA, Glendale CA, Beverly Hills CA,
Sponsor: Neonc Technologies, Inc.
Sex: All
Age: 18+
Code: NCT06047379
Phase 1, Phase 2, Recruiting
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
for
Multiple Myeloma, Myeloma, Myeloma Multiple
Location: Tacoma WA, San Francisco CA, Rochester MN, Dallas TX,
Sponsor: K36 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05651932
Phase 1, Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
for
Breast Neoplasms
Location: Tacoma WA, Reno NV, Saskatoon, Grand Junction CO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07060807
Phase 3, Recruiting
LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC
for
EGFRI Induced Acneiform Lesions
Location: Tacoma WA, Glendale CA, Santa Monica CA, Shreveport LA,
Sponsor: Lutris Pharma Ltd.
Sex: All
Age: 18+
Code: NCT04759664
Phase 2, Recruiting
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
for
Breast Neoplasms, Carcinoma, Ductal, Breast,
Location: Tacoma WA, Puyallup WA, Stockton CA, Greenbrae CA,
Sponsor: Natera, Inc.
Sex: All
Age: 18+
Code: NCT07214532
Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Tacoma WA, Olympia WA, Yakima WA, Salem OR, Spokane WA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
for
Stroke, PFO - Patent Foramen Ovale
Location: Tacoma WA, Portland OR, San Francisco CA,
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18 - 70
Code: NCT03821129
Recruiting
Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial
for
Lung Carcinoma
Location: Auburn WA, Shelton WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT07176000
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Gig Harbor WA, Federal Way WA, Tacoma WA,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT07028853
Phase 3, Recruiting
Ambulatory Long Length URodynamics Evaluation
for
Urology, Urinary Bladder, Overactive,
Location: Auburn WA, Sioux Falls SD, Arlington TX, St Louis MO,
Sponsor: Bright Uro
Sex: All
Age: 22+
Code: NCT07425015
Recruiting
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
for
Advanced Colorectal Carcinoma,
Location: Renton WA, Bellingham WA, Longview WA, Vancouver WA,
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT06073431
Recruiting
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer, c-MET
Location: Renton WA, Edmonton, Lancaster CA, Duarte CA,